Teva Branded Pharmaceutical Products R&d Llc
Clinical trials sponsored by Teva Branded Pharmaceutical Products R&d Llc, explained in plain language.
-
New schizophrenia shot matches pill in drug levels, early study shows
Disease control CompletedThis study tested a new long-acting olanzapine injection (TV-44749) against the standard olanzapine pill in 153 adults with schizophrenia. The goal was to see if the shot delivers the same amount of medicine into the body as the pill. Researchers also checked for side effects. Th…
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New migraine shot shows promise for kids as young as 6
Disease control CompletedThis study tested the long-term safety of a monthly shot called fremanezumab to prevent migraine in children and teens aged 6 to 17. Over 500 participants received the drug for up to 84 months. The goal was to see if the treatment is safe and helps reduce migraine days over time.
Phase: PHASE3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Healthy volunteers help test new drug formulations
Knowledge-focused CompletedThis study tested how well new versions of the drug TEV-56286 are absorbed into the body compared to the original capsule. It involved 47 healthy adults who took single doses of different formulations. The main goal was to measure drug levels in the blood, and safety was also mon…
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Knowledge-focused
Last updated May 01, 2026 18:42 UTC